Lipids in association with serum magnesium in diabetes mellitus patients

Bratislava Medical Journal

Volumn 109, Issue 7, 2008, Pages 302-306

  Nasri, Hamid ^a,b   Baradaran, Hamid Reza ^a,b  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Laboratory of Pathobiology   (Iran)

Author keywords

Diabetes mellitus; Lipoprotein(a); Serum lipids; Serum magnesium

Indexed keywords

LIPID; MAGNESIUM;

ARTICLE; BLOOD; DIABETES MELLITUS; FEMALE; HUMAN; MALE; MIDDLE AGED;

DIABETES MELLITUS; FEMALE; HUMANS; LIPIDS; MAGNESIUM; MALE; MIDDLE AGED;

EID: 57049125683     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Levine C, Colburn JW. Magnesium, the mimic/antagonist of calcium. New Engl J Med 1984; 19: 1253-1254.
2. Gums JG. Clinical significance of magnesium: a review. Drug Intell Clin Pharm 1987; 21: 240-246.
3. Maltezos E et al. Serum magnesium levels in non-diabetic offspring of patients with Type 2 diabetes mellitus. Diabetes Nutr Metab 2004; 17 (1): 12-16.
4. McNair P et al. Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes 1978; 27: 961-965.
5. Mather HM et al. Hypomagnesemia in diabetes. Clin Chem Acta 1979; 95: 235-242.
6. Fuji S et al. Magnesium levels in plasma, erythrocyte and urine in patients with diabetes mellitus. Horn Metab Res 1982; 14: 161-162.
7. Johansson G et al. Evidence for a disturbed magnesium metabolism in diabetes mellitus. Magnesium 1982; 3: 178-180.
8. Ewald U, Gebre-Medhin M, Tuvemo T. Hypomagnesemi in diabetic children. Acta Paediat Scand 1983; 72: 367-371.
9. Tuvemo T et al. Serum magnesium and protein concentrations during the first years of insulin-dependent diabetes in children. Acta Paediat 1997; 418: 7-10.
10. Gebre-Medhin M et al. Dietary intake, trace elements and serum protein status in young diabetics. Acta Paediat Scand 1985; 74 (Suppl): 38-43.
11. Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Amer J Hypertens 1997; 10: 346-355.
12. Paolisso G, Ravussin E. Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians. J Clin Endocrinol Metab 1995; 80: 1382-1385.
13. Lefebvre PJ, Paolisso G, Scheen AJ. Magnesium and glucose metabolism. Therapie 1994; 49: 1-7.
14. Nadler JL et al. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993; 21: 1024-1029.
15. Paolisso G et al. Magnesium and glucose homeostasis. Diabetologia 1990; 33: 511-514.
16. Resnick LM. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders. Amer J Med 1992; 93: 11S-20S.
17. Schnack C et al. Hypomagnesemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-term metabolic control. Diabetologia 1992; 35: 77-79.
18. Isbir T et al. Zinc, cooper and magnesium status in insulin-dependent diabetes. Diabetes Res 1994; 26: 41-45.
19. Fox C et al. Magnesium: it's proven and potential clinical significance. South Med J 2001; 94: 1195-1201.
20. Altura BM, Altura BT. Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases. Fed Proc 1981; 40: 2672-2679.
21. Gerrad JM et al. Alteration in balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med 1980; 95: 950-958.
22. Nadler JL, Rude RK. Disorders of magnesium metabolism. Endocrinol Metab Clin North Amer 1995; 24: 623-641.
23. Nadler JL et al. Intracellular free magnesium defyciency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care 1992; 15: 835-841.
24. Altura BM et al. Magnesium defyciency and hypertension: correlation between magnesium-defycient diets and microcirculatory changes in situ. Science 1984; 223: 1315-1317.
25. Altura BM, Altura BT. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system: Clinical aspects. Magnesium 1985; 4: 226-244.
26. Hagg E et al. Magnesium therapy in type 1 diabetes. A double blind study concerning the effects on kidney function and serum lipid levels. Magnes Res 1999; 12 (2): 123-130.
27. Robles NR et al. Correlation of serum magnesium and serum lipid levels in hemodialysis patients. Dialysis & Transplantation 1998; 27 (10): 644-648.
28. Nasri H, Baradaran A. Correlation of serum magnesium with dyslipidemia in maintenance hemodialysis patients. Acta Med 2004; 47: 4263-4265.
29. Corica F et al. Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. Magnes Res 1994; 7 (1): 43-47.
30. Lal J et al. Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus. J Assoc Physicians India 2003; 51 (1): 37-42.
31. Friedewald WT, Levy R, fredrickson DS. Estimation of the concentration of Low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 799-502.
32. Cockcroft DW, Gault MH. Prediction of creatinin clearance from serum creatinine. Nephron 1976; 16: 31-41.
33. American Diabetic Association. Magnesium supplementation in the treatment of diabetes - a consensus statement. Diabet Care 1992; 15: 1065-1067.
34. Paolisso G et al. Magnesium and glucose homeostasis. Diabetologia 1990; 33: 511-514.
35. Mooradian AD, Morley JE. Micronutrient status in diabetes mellitus. Amer J Clin Nutr 1987; 45: 877-895.
36. Cadell JL. Magnesium in perinatal care and infant health. Magnes Trace Elem 1991-92; 10: 229-250.
37. Wester PO. Magnesium. Amer J Clin Nutr 1987; 45 (Suppl): 1305-1312.
38. Vanroelen WF et al. Serum and erythrocyte magnesium levels in type I & type II diabetics. Acta Diabetol Lat 1985; 22: 185-190.
39. Nadler JL et al. Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type-II diabetes mellitus. Diabet Care 1992; 15: 835-841.
40. Mather HM, Levin GE. Magnesium status in diabetes. Lancet 1979; 1: 924.
41. Smith RG et al. Serum and urinary magnesium, calcium and copper levels in insulin dependent diabetic women. J Trace Elem Electrolytes Health Dis 1988; 2: 239-243.
42. Streter DHP et al. Reduced glucose tolerance in elderly human subjects. Diabetes 1965; 14: 579-583.
43. American Diabetes Association. Magnesium supplementation in the treatment of diabetes. Diabetes Care 1992; 14: 1065-1067.
44. Schroeder HA et al. Abnormal trace metals in man. J Chron Dis 1962; 15: 941-964.
45. Seelig MS, Heggtyeit A. Magnesium interrelationship in ischemic heart disease. Amer J Clin Nutr 1974; 27: 59-79.
46. Stutzman FL, Amatuzio DS. Blood serum magnesium in portal cirrhosis and diabetes mellitus. J Lab Clin Ned 1953; 41: 215-219.
47. Seeling MS, Heggtveit HA. Magnesium interrelationships in ischemic heart disease: a review. Amer J Clin Nutr 1974; 27: 59-79.
48. Ceriello A et al. Hypomagnesemia in relation to diabetic retinopathy. Diabet Care 1980; 5: 558-559.
49. Rude K et al. Parathyroid hormone secretion in magnesium defyciency. J Clin Endocrinol Metab 1978; 47: 800-806.
50. Rude K et al. Parathyroid hornyone secretion in magnesium defyciency. J Clin Endocrinol Metab 1985; 61: 933-940.
51. Baydas B, Karagos S, Meral I. Effects of oral zinc and magnesium supplementation on serum thyroid hormone and lipid levels in experimentally induced diabetic rats. Biol Trace Elem Res 2002; 88 (3): 247-253.
52. Heesen BJ et al. Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin dependent diabetes. Eur J Clin Invest 1993; 23: 580-584.
53. Purvis JR, Movahed A. Magnesium disorders and cardiovascular diseases. Eur J Clin Invest 1992; 15 (8): 556-568.